Improvement in Key PsA Core Domains With Guselkumab Treatment in an Enriched Population of ACR20 Non-responders at Week 24: Post Hoc Analysis of Two Phase 3 Studies

Authors
Publication date
1 January 2023
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    White Rose Research Online

    redirect
    oaioai:eprints.whiterose.ac.uk:20...
    Last time updated on 05/02/2024